17.50
0.29 (1.69%)
| Penutupan Terdahulu | 17.21 |
| Buka | 17.16 |
| Jumlah Dagangan | 425,628 |
| Purata Dagangan (3B) | 420,391 |
| Modal Pasaran | 6,198,321,152 |
| Harga / Pendapatan (P/E Ke hadapan) | 17.15 |
| Harga / Jualan (P/S) | 1.21 |
| Harga / Buku (P/B) | 0.940 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -7.50% |
| Margin Operasi (TTM) | -5.36% |
| EPS Cair (TTM) | -1.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 75.07% |
| Nisbah Semasa (MRQ) | 1.56 |
| Aliran Tunai Operasi (OCF TTM) | 166.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 69.00 M |
| Pulangan Atas Aset (ROA TTM) | 0.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Menurun | |
| Stok | Bausch + Lomb Corporation | Menaik | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | -0.75 |
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 88.13% |
| % Dimiliki oleh Institusi | 10.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Icahn Carl C | 30 Sep 2025 | 3,500,000 |
| Goldentree Asset Management Lp | 30 Sep 2025 | 2,660,508 |
| Silver Point Capital L.P. | 30 Sep 2025 | 2,565,000 |
| Diameter Capital Partners Lp | 30 Sep 2025 | 1,215,893 |
| Compass Rose Asset Management, Lp | 30 Sep 2025 | 1,000,000 |
| Davidson Kempner Capital Management Lp | 30 Sep 2025 | 980,474 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 21.00 (Morgan Stanley, 20.00%) | Beli |
| Median | 17.50 (0.00%) | |
| Rendah | 16.00 (JP Morgan, -8.57%) | Pegang |
| Purata | 18.00 (2.86%) | |
| Jumlah | 4 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 15.65 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Evercore ISI Group | 05 Jan 2026 | 18.00 (2.86%) | Pegang | 16.80 |
| 30 Oct 2025 | 18.00 (2.86%) | Beli | 15.14 | |
| Morgan Stanley | 02 Dec 2025 | 21.00 (20.00%) | Beli | 17.05 |
| RBC Capital | 14 Nov 2025 | 19.00 (8.57%) | Beli | 15.60 |
| Wells Fargo | 14 Nov 2025 | 17.00 (-2.86%) | Pegang | 15.60 |
| 30 Oct 2025 | 16.00 (-8.57%) | Pegang | 15.14 | |
| Barclays | 31 Oct 2025 | 17.00 (-2.86%) | Pegang | 14.94 |
| HC Wainwright & Co. | 31 Oct 2025 | 17.00 (-2.86%) | Beli | 14.94 |
| JP Morgan | 30 Oct 2025 | 16.00 (-8.57%) | Pegang | 15.14 |
| Raymond James | 30 Oct 2025 | 19.00 (8.57%) | Beli | 15.14 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |